Spirulina and Glycolysis Regulation: PFK-1, PKM2, and the Warburg Effect

Glycolytic Pathway Regulation

Glycolysis converts glucose to pyruvate through 10 enzymatic steps. Three irreversible steps are regulatory: (1) hexokinase (HK1/2), phosphorylating glucose to glucose-6-P, inhibited by its product; (2) phosphofructokinase-1 (PFK-1), converting fructose-6-P to fructose-1,6-bisphosphate (F1,6BP), activated by AMP/ADP/fructose-2,6-bisphosphate (F2,6BP) and inhibited by ATP and citrate; (3) pyruvate kinase M1/M2 (PKM1/PKM2), converting phosphoenolpyruvate to pyruvate. PFKFB3 (6-phosphofructo-2-kinase/ fructose-2,6-bisphosphatase 3) synthesises F2,6BP, the potent PFK-1 allosteric activator; PFKFB3 is phosphorylated and activated by AMPK.

AMPK and Glycolytic Flux in Energy Stress

Under energy stress (low ATP/AMP ratio), AMPK phosphorylates PFKFB3 Ser461, increasing F2,6BP and stimulating PFK-1, acutely enhancing glycolytic flux to restore ATP. This is adaptive in contracting muscle or ischaemic tissue. Simultaneously, AMPK inhibits glycogen synthase (Ser641) and activates glycogen phosphorylase, shifting glucose from storage to glycolysis. Spirulina-induced AMPK activation thus creates a transient pro-glycolytic state in energy-stressed tissues while also activating OXPHOS (mitochondrial biogenesis via PGC-1alpha), making the net effect a preference for efficient aerobic metabolism over anaerobic glycolysis.

HIF-1alpha and the Warburg Effect

HIF-1alpha drives the Warburg shift (aerobic glycolysis) by transcriptionally inducing: glucose transporters (GLUT1/SLC2A1, GLUT3), glycolytic enzymes (HK2, ALDOA, PGAM1, ENO1, LDHA), PDHA kinase (PDK1, phosphorylating and inactivating PDH to reduce mitochondrial pyruvate entry), and MCT4 (lactate exporter). HIF-1alpha protein is normally hydroxylated at Pro402/Pro564 by PHDs (prolyl hydroxylases, require O2/alpha-KG) and ubiquitinated by VHL for proteasomal degradation. NF-kB and ROS stabilise HIF-1alpha under normoxia. PCB-driven NF-kB suppression and ROS reduction by spirulina attenuate normoxic HIF-1alpha stabilisation, reducing the Warburg phenotype in inflammatory or tumour microenvironments.

PKM2: Glycolytic and Nuclear Functions

Pyruvate kinase M2 (PKM2) is expressed in embryonic and cancer cells (versus the constitutively active tetrameric PKM1 in differentiated cells). PKM2 can be inhibited by phosphotyrosine-containing proteins (from receptor tyrosine kinase signalling) via competitive displacement of the allosteric activator fructose-1,6-bisphosphate, diverting glycolytic intermediates to biosynthesis (pentose phosphate pathway, serine synthesis). In addition, PKM2 translocates to the nucleus where it acts as a protein kinase for histone H3 Thr11 and STAT3 Tyr705, driving pro-tumour transcription. Spirulina's AMPK-driven metabolic reprogramming reduces RTK signalling (reducing PKM2 nuclear translocation) and its PCB suppresses NF-kB/STAT3.

Lactate and the Tumour/Immune Microenvironment

Warburg-active tumour cells export lactate via MCT4, acidifying the extracellular space. This lactate/acid microenvironment suppresses CTL and NK cell function (glycolysis-dependent), promotes M2 macrophage polarisation, and stabilises HIF-1alpha in tumour cells. Spirulina's attenuation of Warburg metabolism (via HIF-1alpha and PKM2 suppression) would reduce lactate production, partially restoring T cell and NK cell metabolic competence in the tumour microenvironment, synergising with immune checkpoint inhibitor therapy in preclinical contexts.

Gluconeogenesis Suppression vs. Glycolysis Activation

In the fasted liver, AMPK simultaneously activates glycolysis (via PFKFB3) and suppresses gluconeogenesis (via TORC2/CRTC2 cytoplasmic sequestration reducing PEPCK and G6Pase transcription), reducing hepatic glucose output. Spirulina in type 2 diabetes animal models consistently lowers fasting blood glucose, mechanistically consistent with AMPK-driven suppression of hepatic gluconeogenesis alongside muscle glucose uptake enhancement (GLUT4 translocation via AS160 phosphorylation).